Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding Study of MR-130A-01 Contraceptive Patch
NCT06048536Phase 2Completed
- Sponsor
- Mylan
- Start
- Dec 2023
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of norelgestromin in contraception, sponsored by Mylan. Started Dec 2023; status: completed.
02
Drugs
norelgestromin
03
Conditions
contraception
Beyond the preview
Go deeper on NCT06048536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06048536.